Evidence map›Paper›PMID 38769020›Full record

ArticleMolecular pharmacology2024

Biasing G

Gissell A Sanchez, Alan V Smrcka, Emily M Jutkiewicz

Abstract read
In one paragraph

Article in Molecular pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gissell A SanchezDepartment of Pharmacology, University of Michigan, Ann Arbor, Michigan.
Alan V SmrckaDepartment of Pharmacology, University of Michigan, Ann Arbor, Michigan ejutkiew@umich.edu avsmrcka@umich.edu.
Emily M JutkiewiczDepartment of Pharmacology, University of Michigan, Ann Arbor, Michigan.

Funding

Development of G protein beta gamma subunit inhibitors to improve the safety and efficacy of opioid analgesicsR01DA048625 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JUTKIEWICZ, EMILY M, SMRCKA, ALAN V. · 2019 to 2023
$3.6M
NIDA NIH HHS DA048625-S1NIDA NIH HHS R01 DA048625
6 · The paper itself

Abstract

Opioid analgesics are widely used as a treatment option for pain management and relief. However, the misuse of opioid analgesics has contributed to the current opioid epidemic in the United States. Prescribed opioids such as morphine, codeine, oxycodone, and fentanyl are mu-opioid receptor (MOR) agonists primarily used in the clinic to treat pain or during medical procedures, but development of tolerance limits their utility for treatment of chronic pain. Here we explored the effects of biasing G

Indexed as

Analgesics, OpioidDrug ToleranceGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsMice, Inbred C57BLMorphineNociceptionSignal TransductionAnimalsMaleMicePhospholipase C betaReceptors, Opioid, muXanthenesAnalgesics, OpioidgalleinGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsMorphinePhospholipase C betaReceptors, Opioid, muXanthenes

Identifiers

PMID38769020
PMCPMC11187686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.